 LAKEWOOD, CO ACCESSWIRE March 17, 2020 General Moly, Inc. General Moly or the Company NYSE American and TSX: GMO, the only western-exchange listed, pure-play molybdenum moly mineral development company, previously announced that on September 12, 2019, it received a deficiency letter Letter from the NYSE American stock exchange indicating that pursuant to Section 1003fv of the NYSE American Company Guide, the Companys common stock has been selling for a low price per share for a substantial period of time. The Letter stated that the Company must demonstrate an improved share price improvement or effect a reverse stock split of its common stock by no later than March 12, 2020, in order to maintain the listing of the Companys common stock on the NYSE American. 